Chatham Capital Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.69M Sell
34,213
-214
-0.6% -$49.9K 1.11% 22
2026
Q1
$8.42M Buy
34,427
+10
+0% +$2.33K 1.22% 19
2025
Q4
$7.12M Sell
34,417
-249
-0.7% -$49.2K 1.01% 24
2025
Q3
$6.43M Sell
34,666
-1,923
-5% -$329K 0.92% 28
2025
Q2
$5.59M Sell
36,589
-12,614
-26% -$1.94M 0.85% 33
2025
Q1
$8.16M Sell
49,203
-1,548
-3% -$242K 1.36% 16
2024
Q4
$7.34M Sell
50,751
-863
-2% -$134K 1.21% 20
2024
Q3
$8.36M Buy
51,614
+29
+0.1% +$4.62K 1.37% 17
2024
Q2
$7.54M Buy
51,585
+391
+0.8% +$58.2K 1.32% 17
2024
Q1
$8.1M Buy
51,194
+309
+0.6% +$49.2K 1.49% 13
2023
Q4
$7.98M Buy
50,885
+274
+0.5% +$42K 1.61% 13
2023
Q3
$7.88M Sell
50,611
-932
-2% -$154K 1.76% 11
2023
Q2
$8.53M Buy
51,543
+1,182
+2% +$191K 1.8% 9
2023
Q1
$7.81M Sell
50,361
-203
-0.4% -$32.8K 1.74% 9
2022
Q4
$8.93M Sell
50,564
-2,074
-4% -$358K 2.09% 5
2022
Q3
$8.6M Buy
52,638
+661
+1% +$112K 2.11% 7
2022
Q2
$9.23M Sell
51,977
-154
-0.3% -$27.4K 2.09% 8
2022
Q1
$9.24M Sell
52,131
-735
-1% -$125K 1.79% 13
2021
Q4
$9.04M Sell
52,866
-736
-1% -$120K 1.63% 17
2021
Q3
$8.66M Sell
53,602
-672
-1% -$115K 1.67% 15
2021
Q2
$8.94M Buy
54,274
+1,057
+2% +$175K 1.73% 14
2021
Q1
$8.75M Buy
53,217
+196
+0.4% +$31.7K 1.83% 13
2020
Q4
$8.34M Sell
53,021
-231
-0.4% -$34.1K 1.88% 13
2020
Q3
$7.93M Sell
53,252
-1,622
-3% -$240K 1.95% 11
2020
Q2
$7.72M Sell
54,874
-1,341
-2% -$195K 2% 10
2020
Q1
$7.37M Sell
56,215
-81
-0.1% -$11.5K 2.18% 9
2019
Q4
$8.21M Sell
56,296
-1,537
-3% -$208K 2.02% 10
2019
Q3
$7.48M Sell
57,833
-2,570
-4% -$339K 1.91% 12
2019
Q2
$8.41M Sell
60,403
-184
-0.3% -$25.5K 2.12% 8
2019
Q1
$8.47M Sell
60,587
-1,331
-2% -$178K 2.18% 8
2018
Q4
$7.99M Buy
61,918
+3,535
+6% +$493K 2.22% 10
2018
Q3
$8.07M Buy
58,383
+469
+0.8% +$62.3K 2.04% 11
2018
Q2
$7.03M Buy
57,914
+215
+0.4% +$26.8K 1.85% 18
2018
Q1
$7.39M Buy
57,699
+137
+0.2% +$18.5K 1.99% 13
2017
Q4
$8.04M Sell
57,562
-214
-0.4% -$29.8K 2.21% 12
2017
Q3
$7.51M Buy
57,776
+503
+0.9% +$66.7K 2.13% 12
2017
Q2
$7.58M Sell
57,273
-1,754
-3% -$224K 2.1% 13
2017
Q1
$7.33M Buy
59,027
+2,278
+4% +$272K 2.05% 15
2016
Q4
$6.54M Buy
56,749
+1,939
+4% +$224K 1.91% 14
2016
Q3
$6.47M Sell
54,810
-475
-0.9% -$57.6K 2.04% 14
2016
Q2
$6.71M Sell
55,285
-564
-1% -$64.1K 2.07% 14
2016
Q1
$6.04M Buy
55,849
+1,502
+3% +$156K 1.91% 13
2015
Q4
$5.58M Sell
54,347
-1,017
-2% -$102K 1.79% 16
2015
Q3
$5.17M Sell
55,364
-119
-0.2% -$11.5K 1.74% 17
2015
Q2
$5.41M Sell
55,483
-884
-2% -$88.5K 1.52% 21
2015
Q1
$5.67M Sell
56,367
-9,373
-14% -$953K 1.66% 17
2014
Q4
$6.87M Sell
65,740
-248
-0.4% -$26.1K 2.05% 12
2014
Q3
$7.03M Buy
65,988
+3,842
+6% +$398K 2.19% 11
2014
Q2
$6.5M Buy
62,146
+1,103
+2% +$111K 2.55% 9
2014
Q1
$6M Buy
61,043
+14,211
+30% +$1.32M 2.48% 12
2013
Q4
$4.29M Buy
46,832
+103
+0.2% +$9.49K 1.78% 20
2013
Q3
$4.05M Sell
46,729
-347
-0.7% -$31.1K 1.84% 18
2013
Q2
$4.04M Buy
+47,076
New +$3.99M 1.97% 17

Other funds holding JNJ

Chatham Capital Group's JNJ Position: Q2 2026 in Review

Chatham Capital Group reduced its Johnson & Johnson (JNJ) stake by 0.62% in Q2 2026, selling an estimated $49.9K and leaving 34,213 shares worth $8.69M. The position accounts for 1.11% of the portfolio, ranked #22.

Chatham Capital Group first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.24M in Q1 2022. 899 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Chatham Capital Group held 34,213 shares of Johnson & Johnson worth $8.69M as of Q2 2026.
  • Chatham Capital Group sold 214 Johnson & Johnson shares in Q2 2026, an estimated $49.9K.
  • Johnson & Johnson made up 1.11% of Chatham Capital Group's portfolio in Q2 2026, its #22 holding.
  • Chatham Capital Group first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Chatham Capital Group's Johnson & Johnson position peaked at $9.24M in Q1 2022.
  • 899 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Chatham Capital Group's 13F filing for Q2 2026, filed 13 Jul 2026.